NCT07194421

In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 42 (actual)
• Sponsor: Pierre Fabre Dermo Cosmetique · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates a broad-spectrum SPF50+ sunscreen on 42 adults with Atopic Dermatitis, measuring skin tolerance and barrier function. The study includes several visits as follow : * Visit 1: Inclusion (Day 1) * Visit 2: Intermediate Visit (Day 8) * Visit 3: End of Study (Day 22)

Conditions

• Atopic Dermatitis (AD)
• SCORAD Index(15-25)

Interventions

Type	Name	Description
OTHER	Sunscreen RV4620A RP2552	Dermo-cosmetic product, Broadspectrum Sunscreen RV4620A RP2552, very high protection product Instructions for product use given to the subjects: Apply before and during sun exposure, at least twice daily. During sun exposure, applications must be renewed as often as necessary, in particular after swimming, perspiring, towelling, in order to ensure a good protection. On days of bad weather, apply the product in the morning and at the beginning of the afternoon.

Timeline

• Start date: 2023-10-10
• Primary completion: 2024-02-09
• Completion: 2024-02-09
• First posted: 2025-09-26
• Last updated: 2025-09-26

Locations

1 site across 1 country: Mauritius